<div id="readability-page-1"><p>Waystar Holding Corp. (NASDAQ:WAY - Get Free Report) insider Eric (Ric) Sinclair III sold 40,225 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total transaction of $1,209,968.00. Following the completion of the transaction, the insider owned 474,826 shares in the company, valued at $14,282,766.08. The trade was a 7.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.</p><h2>Waystar Stock Down 0.2%</h2><p>Waystar stock traded down $0.05 during trading on Thursday, reaching $29.51. 1,430,981 shares of the company's stock were exchanged, compared to its average volume of 2,041,025. The company's 50-day moving average is $33.28 and its two-hundred day moving average is $35.77. The company has a debt-to-equity ratio of 0.38, a quick ratio of 3.89 and a current ratio of 3.89. Waystar Holding Corp. has a 52-week low of $28.71 and a 52-week high of $48.11. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 47.60, a PEG ratio of 0.37 and a beta of 0.76. </p><h2>Analysts Set New Price Targets</h2><p>Several brokerages recently weighed in on WAY. Canaccord Genuity Group  set a $54.00 price objective on Waystar in a report on Thursday, October 30th. Wells Fargo &amp; Company initiated coverage on Waystar in a report on Thursday, January 8th. They set an &#34;overweight&#34; rating and a $41.00 price target on the stock. UBS Group initiated coverage on Waystar in a research note on Monday, December 15th. They set a &#34;buy&#34; rating and a $41.00 price target for the company. Citigroup decreased their price target on shares of Waystar from $49.00 to $46.00 and set a &#34;buy&#34; rating on the stock in a research report on Friday, January 9th. Finally, Zacks Research cut shares of Waystar from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Thursday, January 1st. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, Waystar  has a consensus rating of &#34;Buy&#34; and an average target price of $46.64.</p><p><b>Get Our Latest Research Report on Waystar</b></p><h2>Institutional Trading of Waystar</h2><p>Hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in shares of  Waystar by 11.3% during the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company's stock worth $808,000 after purchasing an additional 2,195 shares during the period.  AQR Capital Management LLC bought a new stake in shares of  Waystar during the first quarter worth $203,000.  MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of  Waystar by 91.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company's stock worth $1,753,000 after buying an additional 22,364 shares during the period.  NewEdge Advisors LLC bought a new position in shares of  Waystar in the 1st quarter worth $234,000.  Finally, Goldman Sachs Group Inc. increased its stake in shares of  Waystar by 13.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company's stock valued at $27,918,000 after acquiring an additional 88,256 shares during the last quarter. </p><h2>About Waystar</h2> (Get Free Report)<p>Waystar <span>NASDAQ: WAY<span></span></span> is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.  </p><p>At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Waystar</li><li>Trump’s AI Secret: 100X Faster Than Nvidia</li><li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li><li>New gold price target</li><li>The $100 Trillion AI Story No One Is Telling You</li><li>Trump Did WHAT??</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0FZ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0FZ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Waystar Right Now?</h2><p>Before you consider Waystar, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.</p><p>While Waystar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CLOU

<p>Waystar Holding Corp. insider Eric Sinclair III sold 40,225 shares at $30.08, totaling $1,209,968, reducing his stake by 7.81%. Post-sale, he holds 474,826 shares valued at approximately $14.28 million. The stock is currently down 0.2% at $29.51. Analysts have set price targets ranging from $41 to $54, with a consensus rating of "Buy" and an average target price of $46.64. Waystar is a cloud-based revenue cycle management provider for healthcare organizations.</p>

Insider Selling: Waystar (NASDAQ:WAY) Insider Sells $1,209,968.00 in Stock